Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study – The Lancet Respiratory Medicine (link to abstract – $ for full-text)   Commentary on Twitter NEW—Pulmonary vascular resistance reduction was more pronounced with balloon pulmonary angioplasty (BPA) […]

The post RCT | Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension. appeared first on Links Medicus.